Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: An exploratory outcomes analysis

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 3, 2005, Pages 684-689

  Taussky, Daniel ^a,d   Rufibach, Kaspar ^b   Huguenin, Pia ^c   Allal, Abdelkarim S ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

Chemotherapy; Head and neck cancer; Radiotherapy; Second cancer

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS; RISK ASSESSMENT; TUMORS;

EXPLORATORY ANALYSIS; SECOND PRIMARY TUMOR (SPT); SWISS GROUP FOR CLINICAL CANCER RESEARCH (SAKK); UPPER AERODIGESTIVE TRACT (UADT);

DIGESTIVE SYSTEM;

CISPLATIN;

ADD ON THERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; INFORMATION RETRIEVAL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; OBSERVATION; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RESPIRATORY TRACT CANCER; RISK FACTOR;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DATABASES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGRESSION ANALYSIS; RISK FACTORS;

EID: 20344381782     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.11.027     Document Type: Article

References (34)

1. K.K. Fu, T.F. Pajak, A. Trotti Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous cell carcinomas First report of RTOG 9030. A Radiation Therapy Oncology Group (RTOG) Int J Radiat Oncol Biol Phys 48 2000 7 16
2. S. Staar, V. Rudat, H. Stuetzer Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 1161 1171
3. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
4. S.M. Lippman, W.K. Hong Second malignant tumors in head and neck squamous cell carcinoma The overshadowing threat for patients with early-stage disease Int J Radiat Oncol Biol Phys 17 1989 691 694
5. X. Gao, S.G. Fisher, N. Mohideen, B. Emami Second primary cancers in patients with laryngeal cancer A population-based study Int J Radiat Oncol Biol Phys 56 2003 427 435
6. X. Leon, M. Quer, S. Diez Second neoplasm in patients with head and neck cancer Head Neck 21 1999 204 210
7. X. Wu, Y. Hu, S.M. Lippman Upper aerodigestive cancers A.I. Neugut A.T. Meadows E. Robinson Multiple primary cancers 1999 Lippincott Williams & Wilkins Philadelphia 319 346
8. E. Yamamoto, H. Shibuya, R. Yoshimura Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma Cancer 94 2002 2007 2014
9. J.S. Cooper, T.F. Pajak, P. Rubin Second malignancies in patients who have head-and-neck cancer Incidence, effect on survival, and implications based on the RTOG experience Int J Radiat Oncol Biol Phys 17 1989 449 456
10. E. Robinson, A. Zauber, Z. Fuks Clinical characteristics of patients with epidermoid carcinoma of the upper aerodigestive tract who develop second malignant tumors Cancer Detect Prev 16 1992 297 303
11. A.F. Forastiere, W. Koch, A. Trotti Head and neck cancer N Engl J Med 346 2001 788
12. X. Wu, Y. Hu, S.M. Lippman Upper aerodigestive cancers A.I. Neugut A.T. Meadows E. Robinson Multiple primary cancers 1999 Lippincott Williams & Wilkins Philadelphia 328 329
13. P. Huguenin, K. Beer, A.S. Allal Concomitant cisplatin significantly improves loco-regional control in advanced head and neck cancers treated with hyperfractionated radiotherapy J Clin Oncol 22 2004 4613 4621
14. A.S. Allal, C. de Pree, P. Dulguerov Avoidance of treatment interruption An unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas? Int J Radiat Oncol Biol Phys 45 1999 41 45
15. H.S. Erkal, W.M. Mendenhall, R.J. Amdur Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites J Clin Oncol 19 2001 1358 1362
16. S. Warren, O. Gates Multiple primary malignant tumors A survey of the literature and statistical study Am J Cancer 51 1932 1358 1414
17. J.S. Cooper, T.F. Pajak, A.A. Forastiere Patterns of failure for resected advanced head-and-neck cancer treated by concurrent chemotherapy and radiation therapy An analysis of RTOG 9501/Intergroup Phase III trial [Abstract] Int J Radiat Oncol Biol Phys 54 2002 2
18. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. J.P. Fine, R.J. Gray A proportional hazards model for the subdistribution of a competing risk JASA 94 1999 496 509
20. O. Aalen Nonparametric estimation of partial transition probabilities in multiple decrement models Ann Stat 6 1978 534 545
21. A.I. Neugut, A.T. Meadows, E. Robinson Introduction A.I. Neugut A.T. Meadows E. Robinson Multiple primary cancers 1999 Lippincott Williams & Wilkins Philadelphia 6 8
22. J.T. Licciardello, M.R. Spitz, W.K. Hong Multiple primary cancer in patients with cancer of the head and neck Second cancer of the head and neck, esophagus, and lung Int J Radiat Oncol Biol Phys 17 1989 467 476
23. G.C. Bedi, W.H. Westra, E. Gabrielson, W. Koch, D. Sidransky Multiple head and neck tumors Evidence for a common clonal origin Cancer Res 56 1996 2484 2487
24. L. Mao, J.S. Lee, Y.H. Fan Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment Nat Med 2 1996 682 685
25. B.J. Sanderson, L.R. Ferguson, W.A. Denny Mutagenic and carcinogenic properties of platinum-based anticancer drugs Mutat Res 355 1996 59 70
26. M.H. Greene Is cisplatin a human carcinogen? J Natl Cancer Inst 84 1992 306 312
27. R. Chibber, M.J. Ord The mutagenic and carcinogenic properties of three second generation antitumour platinum compounds A comparison with cisplatin Eur J Cancer Clin Oncol 25 1989 27 33
28. E.J. Hall, C.S. Wuu Radiation-induced second cancers The impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83 88
29. H. Ahsan, B.J. Insel, A.I. Neugut Risk estimates for second primary cancers A.I. Neugut A.T. Meadows E. Robinson Multiple primary cancers 1999 Lippincott Williams & Wilkins Philadelphia 27 53
30. A.L. McDermott, S.N. Dutt, J.C. Watkinson The aetiology of nasopharyngeal carcinoma Clin Otolaryngol 26 2001 82 92
31. J.M. Nam, J.K. McLaughlin, W.J. Blot Cigarette smoking, alcohol, and nasopharyngeal carcinoma: A case-control study among U.S. whites J Natl Cancer Inst 84 1992 619 622
32. J.P. Spano, P. Busson, D. Atlan Nasopharyngeal carcinomas An update Eur J Cancer 39 2003 2121 2135
33. E. Yamamoto, H. Shibuya, R. Yoshimura Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma Cancer 94 2002 2007 2014
34. P.P. Leong, B. Rezai, W.M. Koch Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma Natl Cancer Inst 90 1998 972 977